UK Stocks-Factors to watch on June 30

June 30 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Thursday, with futures FFIc1 down 1.64%.

* IAG: International Airlines Group ICAG.L said it had converted options for 14 A320neo family Airbus jets, announced in 2013, into firm orders for 11 A320neos and three A321neos.

* ASTRAZENECA: AstraZeneca AZN.L said its cancer drug Imfinzi, when given along with neoadjuvant chemotherapy in a late-stage trial, showed promise in helping patients with an aggressive form of lung cancer before surgery.

* OCADO: Ocado OCDO.L has extended its partnership deal with French retailer Groupe Casino CASP.PA , the British online supermarket and technology group said.

* VIRGIN MONEY: BritVirgin Money VMUK.L said it would buy back shares with an initial repurchase of up to 75 million pounds ($91.10 million).

* BUNZL: Bunzl Plc BNZL.L said it expected higher annual revenue, supported by red-hot inflation and benefits of acquisitions in the past year.

* TESCO: U.S. food giant Kraft Heinz KHC.O has stopped supplying some products to Britain's biggest supermarket group Tesco TSCO.L , which resisted charging its customers higher prices for them at a time of surging inflation.

* BRITISHVOLT: Electric vehicle (EV) battery startup Britishvolt has signed a deal with South Korean battery materials firm Posco Chemical 003670.KS designed to secure the supply of cathode and anode materials, the two companies said.

* TEVVA: British commercial EV startup Tevva launched its first truck with a hydrogen fuel cell booster which should drive up to 310 miles (499 km) and provide fleet operators with greater zero-emission range.

* STRIKE ACTION: British postal workers and train station staff have voted in favour of strike action, their trade unions said.

* CAR PRODUCTION: Britain's car production snapped a ten-month slump in May with a rise of 13.3% as the output of electric vehicles more than doubled and the sector recovered from pandemic lows, industry data showed.

* FTSE 100: Britain's top share index inched lower on Wednesday, as gains in healthcare shares were seen providing little support against growing concerns about a global recession.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Aby Jose Koilparambil and Amna Karimi in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.